These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 357051

  • 1. Effect of niridazole in cellular immunity in vivo and in vitro.
    Solbach W, Wagner H, Röllinghoff M.
    Clin Exp Immunol; 1978 Jun; 32(3):411-8. PubMed ID: 357051
    [Abstract] [Full Text] [Related]

  • 2. Marked suppression of cell-mediated immunity with niridazole: first report.
    Mahmoud AA, Warren KS, Mandel MA.
    Surg Forum; 1974 Jun; 25(0):514-6. PubMed ID: 4612800
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells).
    Perez MI, Edelson RL, John L, Laroche L, Berger CL.
    Yale J Biol Med; 1989 Jun; 62(6):595-609. PubMed ID: 2636801
    [Abstract] [Full Text] [Related]

  • 4. Marked prolongation of skin homograft survival with niridazole. A first report.
    Mandel MA, Mahmoud AA, Warren KS.
    Plast Reconstr Surg; 1975 Jan; 55(1):76-89. PubMed ID: 1089984
    [Abstract] [Full Text] [Related]

  • 5. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
    Williams IR, Perry LL.
    J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the mechanism of allograft rejection and cell-mediated immunity. II. Divergent effect of CY pretreatment on the generation of cytotoxic activity in the draining lymph nodes and spleen.
    Nanishi F, Taniguchi K, Kubo C, Onoyama K, Omae T, Nomoto K.
    J Clin Lab Immunol; 1983 Sep; 12(1):23-30. PubMed ID: 6631941
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK, Shelby J, Eichwald EJ.
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection.
    Orosz CG, Sirinek LP, Zinn NE, Ferguson RM.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.
    Perez M, Edelson R, Laroche L, Berger C.
    J Invest Dermatol; 1989 May; 92(5):669-76. PubMed ID: 2523941
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J, Isobe M, Yamagami S, Mizuochi T, Tsuru T.
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.